Insulin-derived amyloidosis

CMAJ. 2022 Dec 5;194(47):E1616. doi: 10.1503/cmaj.220531.
No abstract available

MeSH terms

  • Amyloidosis* / diagnosis
  • Humans
  • Hypoglycemic Agents
  • Insulin* / therapeutic use

Substances

  • Insulin
  • Hypoglycemic Agents